OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy (Q83868301)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 June 2006
edit
Language Label Description Also known as
English
OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy
scientific article published on 01 June 2006

    Statements

    OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit